Heavy menstrual bleeding raises heart disease risk in young women

FHS
May 28, 2024
5:00 am

Study found that heavy menstrual bleeding (HMB) is linked to increased cardiovascular disease (CVD) risk in young women, even without irregular menstruation.

CureVac Announces Update to the Management Team – Biotech Investments

Issuer: CureVac / Key word(s): Personnel 14.07.2023 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Announces Update to

July 15, 2023

Measuring blood plasma viscosity in COVID-19 using Brillouin light scattering spectroscopy

A research team led by MedUni Vienna has shown in a study that purely optical measurements of the viscosity of blood plasma may provide information

August 6, 2024

What’s my age again? Predicting disease and aging effects by studying organ aging using plasma proteomics data

Researchers performed a proteomic analysis to identify serologic indicators of organ aging and disease.

December 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.